1. Aoki R. A comparison of the safety margins of the botuline neurotoxin serotypes A, B and F in mice. Toxicon 2001;39:1815-20.
2. Hambleton P, Moore AP. Botuline neurotoxins: origin, structure, molecular actions and antibodies. In: AP Moore (ed). Handbook of botuline toxin treatment. Oxford: Blackwell Science, 1995:16-27.
3. Jankovic J. Extent of clinical problem, measurement of clinical resistance, development of antibodies, review of assay options. Toxins 1999;1(1):4.
4. Nusgens Z, Roggenkamper P. Comparison of two Botuline toxin preparations in the treatment of essential blepharospasm. Graefe's Arch Clin Exp Ophthalmol 1997;235:197-9.
5. Boghen DR, Lesser RL. Blepharospasm and hemifacial spasm. Corporate Library 2001;389(July):1-8.